(Q39172696)

9 September 2017

title

AhR expression is increased in hepatocellular carcinoma (English)

1 reference

9 September 2017

Ziyu Liu

1

1 reference

9 September 2017

Xing'an Wu

2

1 reference

9 September 2017

Fanglin Zhang

3

1 reference

9 September 2017

Lurong Han

4

1 reference

9 September 2017

Guoqiang Bao

5

1 reference

9 September 2017

Xianli He

6

1 reference

9 September 2017

Zhikai Xu

7

1 reference

9 September 2017

publication date

2 April 2013

1 reference

Journal of Molecular Histology

9 September 2017

published in

1 reference

9 September 2017

volume

44

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

455-461

1 reference

Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The effect of aryl hydrocarbon receptor ligands on the expression of polymerase (DNA directed) kappa (Polκ), polymerase RNA II (DNA directed) polypeptide A (PolR2a), CYP1B1 and CYP1A1 genes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Therapeutic potential of dithiolethiones for hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Ligand binding and activation of the Ah receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Expression of aryl hydrocarbon receptor in human placentas and fetal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Effects of flavored mineral waters on AhR-CYP1A1 signaling pathway in primary human hepatocytes and in human hepatic and intestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

The aryl hydrocarbon receptor as a promoter of malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Roles for rat hepatocyte malignant transforming factor (HMTF) in late stage of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Gene expression profiles in hepatocellular carcinoma: not yet there

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-013-9495-6

Overexpression of cytochrome P450 1B1 in advanced non-small cell lung cancer: a potential therapeutic target.

21 January 2018

1 reference

12 December 2020

Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gsta1, in murine hepatoma Hepa 1c1c7 cells.

1 reference

12 December 2020

Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice

1 reference

12 December 2020

Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.

1 reference

12 December 2020

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma

1 reference

12 December 2020

From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression

1 reference

12 December 2020

10.1007/S10735-013-9495-6

Identifiers

DOI

1 reference

9 September 2017

1 reference